| FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
| HYKK |
A2RU49
|
hydroxylysine kinase
|
|
7.3E-06 |
0.769 |
0.346 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| SH2B1 |
Q9NRF2
|
SH2B adaptor protein 1
|
|
0.97 |
0.566 |
0.731 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| NRXN3 |
Q9HDB5 Q9Y4C0
|
neurexin 3
|
|
1.00 |
0.656 |
0.615 |
| PDE1C |
Q14123
|
phosphodiesterase 1C
|
|
5.4E-09 |
0.700 |
0.423 |
| MIA-RAB4B |
|
MIA-RAB4B readthrough (NMD candidate)
|
|
|
0.821 |
0.385 |
| MALRD1 |
Q5VYJ5
|
MAM and LDL receptor class A domain containing 1
|
|
9.4E-21 |
0.821 |
0.346 |
| RPL18P11 |
|
ribosomal protein L18 pseudogene 11
|
|
|
0.931 |
0.077 |
| PSMA4 |
P25789
|
proteasome 20S subunit alpha 4
|
|
0.60 |
0.716 |
0.385 |
| RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
| LINC01081 |
|
long intergenic non-protein coding RNA 1081
|
|
|
0.931 |
0.115 |
| LINC02135 |
|
long intergenic non-protein coding RNA 2135
|
|
|
|
|
| RAB4B |
P61018
|
RAB4B, member RAS oncogene family
|
|
0.67 |
0.890 |
0.192 |
| EGLN2 |
Q96KS0
|
egl-9 family hypoxia inducible factor 2
|
|
0.72 |
0.604 |
0.731 |
| C1orf100 |
Q5SVJ3
|
chromosome 1 open reading frame 100
|
|
1.3E-07 |
|
|
| VIRMA |
Q69YN4
|
vir like m6A methyltransferase associated
|
|
0.99 |
0.821 |
0.231 |
| EVL |
Q9UI08
|
Enah/Vasp-like
|
|
1.00 |
0.729 |
0.308 |
| BBX |
Q8WY36
|
BBX high mobility group box domain containing
|
|
0.52 |
0.839 |
0.231 |
| RAB3B |
P20337
|
RAB3B, member RAS oncogene family
|
|
0.31 |
0.861 |
0.115 |
| IREB2 |
P48200
|
iron responsive element binding protein 2
|
Enzyme
|
1.00 |
0.619 |
0.577 |
| ADAMTS7 |
Q9UKP4
|
ADAM metallopeptidase with thrombospondin type 1 motif 7
|
Enzyme
|
2.3E-14 |
0.666 |
0.577 |
| CHRNA3 |
P32297
|
cholinergic receptor nicotinic alpha 3 subunit
|
Ion channel
|
1.4E-07 |
0.588 |
0.692 |
| CHRNB4 |
P30926
|
cholinergic receptor nicotinic beta 4 subunit
|
Ion channel
|
0.14 |
0.644 |
0.423 |